Eligo Bioscience raises $20 million to target the microbiome more precisely

See the original posting on TechCrunch

 French startup Eligo Bioscience just raised $20 million to develop next-gen biotherapeutics. Khosla Ventures is leading the round. This is also Khosla Ventures’ first investment in a French startup. Existing investor Seventure Partners is also participating, and the startup received a $2 million grant from the Worldwide Innovation Challenge. Eligo Bioscience has been working on a new way… Read More